CEN Case Reports

, Volume 7, Issue 1, pp 90–93 | Cite as

Renal vein thrombosis complicating severe acute pyelonephritis with renal abscesses and associated bacteraemia caused by extended-spectrum beta-lactamase producing Escherichia coli

  • Stelios F. Assimakopoulos
  • Pantelis Kraniotis
  • Charalambos Gogos
  • Markos Marangos
Case Report


Acute pyelonephritis might be complicated by the formation of renal and perirenal abscesses and very rarely by renal vein thrombosis, which is a life-threatening condition. The main causative agents of acute pyelonephritis are enterobacteriaceae with the incidence of extended-spectrum beta-lactamase (ESBL)-producing strains increasing worldwide. We present the case of a 71-year-old Greek man with history of diabetes mellitus and recent hospitalization, who suffered from severe pyelonephritis with renal abscesses formation and associated bacteraemia caused by ESBL-producing Escherichia coli, complicated by extensive thrombosis of the ipsilateral renal vein and its branches, protruding also in the inferior venal cava. Our patient was effectively treated with anticoagulants and targeted antibiotic therapy, respectively, consisted of low molecular weight heparin transitioned to oral acenocoumarol for 3 months and 2-week course of intravenous meropenem followed by oral fosfomycin for additional 3 weeks as quidded by clinical and computed tomographic follow-up. In conclusion, in complicated urinary infections, caused by ESBL-producing enterobacteriaceae, oral fosfomycin might represent an effective option for step-down therapy of carbapenems, allowing the shortness of the duration of patient’s hospitalization and carbapenem use.


Urinary tract infections Renal abscess Renal vein thrombosis Extended-spectrum beta-lactamase ESBL Fosfomycin 


Compliance with ethical standards

Conflict of interest

The authors have declared that no conflict of interest exists.

Human rights

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    Yildiz H, Van Nieuwenhove S, Doyen M, Yombi JC. Acute pyelonephritis and renal vein thrombosis: a case report and review of the literature. J Infect Chemother. 2016;22:759–61.CrossRefPubMedGoogle Scholar
  2. 2.
    Ben-Ami R, Rodriguez-Bano J, Arslan H, Pitout JD, Quentin C, Calbo ES, et al. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 2009;49:682–90.CrossRefPubMedGoogle Scholar
  3. 3.
    Doi Y, Bonomo RA, Hooper DC, Kaye KS, Johnson JR, Clancy CJ, et al. Gram-negative bacterial infections: research priorities, accomplishments, and future directions of the antibacterial resistance leadership group. Clin Infect Dis. 2017;64:S30–S35.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Llach F. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int. 1985;28:429–39.CrossRefPubMedGoogle Scholar
  5. 5.
    Kumar S, Singh SK, Mavuduru RS, Acharya NC, Agarwal MM, Jha VK, et al. Acute pyelonephritis with renal vein and inferior vena cava thrombosis in a case of hyperhomocysteinemia. Int Urol Nephrol. 2009;41:185–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Tektonidou MG. Identification and treatment of APS renal involvement. Lupus. 2014;23:1276–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Ram R, Adiraju KP, Gudithi S, Dakshinamurty KV. Renal manifestations in paroxysmal nocturnal hemoglobinuria. Indian J Nephrol. 2017;27:289–93.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Kawano PR, Yamamoto HA, Gerra R, Garcia PD, Contti MM, Nga HS, et al. A case report of venous thrombosis after kidney transplantation—we can save the graft? Time is the success factor. Int J Surg Case Rep. 2017;36:82–5.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Harris LA, Van Every MJ, Fundell LJ. Acute bilateral renal vein thrombosis secondary to sepsis from pyelonephritis. Int Braz J Urol. 2012;38:132–4.CrossRefPubMedGoogle Scholar
  10. 10.
    Barros NA, Torrao MM, Ferreira M, Pinheiro A. Left ovarian and renal vein thrombosis after emergency postpartum hysterectomy. BMJ Case Rep. 2016. PubMedCentralGoogle Scholar
  11. 11.
    Libby P, Simon DI. Inflammation and thrombosis: the clot thickens. Circulation. 2001;103:1718–20.CrossRefPubMedGoogle Scholar
  12. 12.
    Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149:315–52.CrossRefPubMedGoogle Scholar
  13. 13.
    Bassetti M, Peghin M, Pecori D. The management of multidrug-resistant Enterobacteriaceae. Curr Opin Infect Dis. 2016;29:583–94.CrossRefPubMedGoogle Scholar
  14. 14.
    Tamma PD, Han JH, Rock C, Harris AD, Lautenbach E, Hsu AJ, et al. Carbapenem therapy is associated with improved survival compared with piperacillin–tazobactam for patients with extended-spectrum beta-lactamase bacteremia. Clin Infect Dis. 2015;60:1319–25.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Lee SH, Jung HJ, Mah SY, Chung BH. Renal abscesses measuring 5 cm or less: outcome of medical treatment without therapeutic drainage. Yonsei Med J. 2010;51:569–73.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Dalla Palma L, Pozzi-Mucelli F, Ene V. Medical treatment of renal and perirenal abscesses: CT evaluation. Clin Radiol. 1999;54:792–7.CrossRefPubMedGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2018

Authors and Affiliations

  • Stelios F. Assimakopoulos
    • 1
  • Pantelis Kraniotis
    • 2
  • Charalambos Gogos
    • 1
  • Markos Marangos
    • 1
  1. 1.Division of Infectious Diseases, Department of Internal MedicineUniversity General Hospital of PatrasPatrasGreece
  2. 2.Department of RadiologyUniversity General Hospital of PatrasPatrasGreece

Personalised recommendations